Debt-to-equity of Krystal Biotech, Inc. from 30 Jun 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Krystal Biotech, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2018 to 30 Sep 2025.
  • Krystal Biotech, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 10%, a 19% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Krystal Biotech, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 10% +2% +19% 30 Sep 2025
Q2 2025 10% +4% +56% 30 Jun 2025
Q1 2025 10% +5% +92% 31 Mar 2025
Q4 2024 10% +4% +77% 31 Dec 2024
Q3 2024 8% +2% +37% 30 Sep 2024
Q2 2024 7% 0% -0.76% 30 Jun 2024
Q1 2024 5% -2% -28% 31 Mar 2024
Q4 2023 6% -3% -35% 31 Dec 2023
Q3 2023 6% -2% -25% 30 Sep 2023
Q2 2023 7% -2% -25% 30 Jun 2023
Q1 2023 7% -1% -14% 31 Mar 2023
Q4 2022 8% +2% +38% 31 Dec 2022
Q3 2022 8% +2% +25% 30 Sep 2022
Q2 2022 9% +4% +93% 30 Jun 2022
Q1 2022 9% +5% +132% 31 Mar 2022
Q4 2021 6% +2% +54% 31 Dec 2021
Q3 2021 6% +3% +108% 30 Sep 2021
Q2 2021 5% +2% +50% 30 Jun 2021
Q1 2021 4% 0% +13% 31 Mar 2021
Q4 2020 4% 0% +11% 31 Dec 2020
Q3 2020 3% -1% -14% 30 Sep 2020
Q2 2020 3% -1% -21% 30 Jun 2020
Q1 2020 3% 0% -13% 31 Mar 2020
Q4 2019 4% +1% +48% 31 Dec 2019
Q3 2019 4% +2% +74% 30 Sep 2019
Q2 2019 4% +2% +70% 30 Jun 2019
Q1 2019 4% 31 Mar 2019
Q4 2018 2% 31 Dec 2018
Q3 2018 2% 30 Sep 2018
Q2 2018 2% 30 Jun 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.